Nevertheless, while pharmacological inhibition of cGAS protects cognitive deficits in mice with tauopathy,[16b] STING inhibition has also been shown to ameliorate AD symptoms in mice with amyloid pathology.[16, 53] This further emphasizes the beneficial effects of restricting cGAS/STING during AD progression. The gene discussed is CGAS; the disease is amyloidosis.